Joshua W Russo

8PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 12, 2025
Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.

Jude Owiredu, Betul Ersoy-Fazlioglu, Larysa Poluben

|May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress.

Andreas Varkaris, Keshan Wang, Mannan Nouri

|Jun 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.

Adam G Sowalsky, Ines Figueiredo, Rosina T Lis

|Dec 16, 2021
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.

Haiyang Guo, Yiming Wu, Mannan Nouri

|Nov 04, 2021
Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting.

Andrea K Miyahira, Jelani C Zarif, Catherine C Coombs

Pageof 2